Paragon 28, Inc. (NYSE:FNA) Receives Consensus Rating of “Buy” from Analysts

Paragon 28, Inc. (NYSE:FNA) has received a consensus rating of “Buy” from the six research firms that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $15.60.

A number of research analysts recently issued reports on the stock. Stephens upgraded shares of Paragon 28 to a “strong-buy” rating in a research note on Monday, December 2nd. Needham & Company LLC reiterated a “buy” rating and issued a $13.00 price target on shares of Paragon 28 in a research note on Monday, January 13th. William Blair downgraded shares of Paragon 28 from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Finally, Canaccord Genuity Group decreased their price target on shares of Paragon 28 from $17.00 to $15.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th.

Paragon 28 Trading Up 2.8 %

NYSE FNA opened at $12.00 on Wednesday. The firm has a 50 day simple moving average of $10.45 and a 200-day simple moving average of $8.32. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.60 and a current ratio of 3.50. Paragon 28 has a one year low of $4.65 and a one year high of $14.79. The firm has a market cap of $1.00 billion, a price-to-earnings ratio of -16.22 and a beta of 1.50.

Paragon 28 (NYSE:FNA) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.01. Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. The business had revenue of $62.30 million during the quarter, compared to analyst estimates of $60.58 million. During the same quarter last year, the firm posted ($0.10) earnings per share. The business’s revenue for the quarter was up 18.0% compared to the same quarter last year. Equities research analysts anticipate that Paragon 28 will post -0.64 EPS for the current fiscal year.

Insider Transactions at Paragon 28

In other news, major shareholder Mvm Partners, Llc sold 4,256 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $10.00, for a total transaction of $42,560.00. Following the completion of the sale, the insider now owns 10,499,960 shares in the company, valued at approximately $104,999,600. The trade was a 0.04 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In the last quarter, insiders sold 273,050 shares of company stock worth $2,819,696. 15.32% of the stock is currently owned by insiders.

Institutional Trading of Paragon 28

Several institutional investors have recently modified their holdings of FNA. Renaissance Technologies LLC acquired a new position in shares of Paragon 28 in the 2nd quarter valued at $419,000. Hsbc Holdings PLC acquired a new position in shares of Paragon 28 in the 2nd quarter valued at $104,000. XTX Topco Ltd increased its stake in Paragon 28 by 36.4% in the 2nd quarter. XTX Topco Ltd now owns 22,335 shares of the company’s stock valued at $153,000 after buying an additional 5,963 shares during the period. Sei Investments Co. acquired a new position in Paragon 28 in the 2nd quarter valued at $531,000. Finally, Cubist Systematic Strategies LLC acquired a new position in Paragon 28 in the 2nd quarter valued at $869,000. Hedge funds and other institutional investors own 63.57% of the company’s stock.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.